Vyome Holdings HIND
NASDAQ HIND
$2.25 -0.03 (-1.32%)
As of: Aug 21, 2026 · 3:38 PM EDT

Vyome Holdings (HIND) Cash & Equivalents (2015 - 2026)

Vyome Holdings (HIND) posted quarterly Cash & Equivalents of $8.8 million for Q1 2026, up 249.73% year-over-year from $2.5 million in Q1 2025, and up 76.54% quarter-over-quarter from $5.0 million in Q4 2025.

Vyome Holdings (HIND) Cash & Equivalents (2015 - 2026) Analysis & Trends

Vyome Holdings' Cash & Equivalents history runs 12 years deep, the most recent figure standing at $8.8 million for Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 249.73% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $8.8 million (up 249.73% YoY), while the FY2025 annual figure was $5.0 million, up 4789.24% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $8.8 million, up from $5.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $15.5 million in Q1 2022, with the low at $12000.0 in Q2 2024.
  • The 5-year median for Cash & Equivalents is $4.6 million (2023), against an average of $5.1 million.
  • The sharpest annual moves came in 2024 and 2025: Cash & Equivalents tumbled 99.74% in 2024, then soared 35091.67% in 2025.
  • Vyome Holdings' Cash & Equivalents stood at $4.0 million in 2022, then gained by 15.27% to $4.6 million in 2023, then plunged by 97.76% to $101904.0 in 2024, then soared by 4789.24% to $5.0 million in 2025, then jumped by 76.54% to $8.8 million in 2026.
  • Business Quant data shows HIND's Cash & Equivalents at $8.8 million in Q1 2026, $5.0 million in Q4 2025, and $5.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 Vyome Holdings 16.07 Mn 8.18 Mn 11,658.00 7.89 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 7.89 Mn
Mar 31, 2026 8.80 Mn
Dec 31, 2025 4.98 Mn
Sep 30, 2025 5.71 Mn
Jun 30, 2025 4.22 Mn
Mar 31, 2025 2.52 Mn
Dec 31, 2024 101,904.00
Sep 30, 2024 800,000.00
Jun 30, 2024 12,000.00
Mar 31, 2024 2.48 Mn
Dec 31, 2023 4.56 Mn
Sep 30, 2023 1.55 Mn
Jun 30, 2023 4.67 Mn
Mar 31, 2023 9.08 Mn
Dec 31, 2022 3.96 Mn
Sep 30, 2022 6.25 Mn
Jun 30, 2022 11.54 Mn
Mar 31, 2022 15.46 Mn
Dec 31, 2021 22.82 Mn
Sep 30, 2021 29.29 Mn